Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript

Quest Diagnostics Incorporated ( NYSE: DGX) Baird Global Healthcare Conference 2025 September 10, 2025 10:50 AM EDT Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division ...
C&EN

Sensitive, Label-Free DNA Diagnostics Based on Near-Field Microwave Imaging

Department of Physics, Sam Houston State University, Huntsville, Texas 77341, Department of Chemical Engineering, Columbia University, New York, New York 10027, Columbia Genome Center, Columbia ...
Investing

Corewell Health, Quest Diagnostics form lab services joint venture

SOUTHFIELD, Mich. - Corewell Health and Quest Diagnostics (NYSE:DGX), a prominent player in the Healthcare Providers & Services industry with a market capitalization of nearly $20 billion and annual ...
Yahoo Finance

Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan

The joint venture, Diagnostic Lab of Michigan, LLC, will be based at a state-of-the-art laboratory facility at the Corewell Health Southfield Center in Southfield, Michigan. The future ...
Medical Device Network

FDA grants breakthrough device designation for Quest Diagnostics’ MRD test

The test offers a sensitive method for detecting minute quantities of ctDNA in the blood. Credit: National Cancer Institute on Unsplash. The US Food and Drug Administration (FDA) has granted ...
360dx

Quest Diagnostics MRD Test Receives FDA Breakthrough Device Designation

NEW YORK – Quest Diagnostics said on Monday the US Food and Drug Administration has granted breakthrough device designation for the firm's Haystack minimal residual disease (MRD) test. Quest said it ...